Status:

COMPLETED

Hydroxychloroquine Efficacy and Safety in Preventing SARS-CoV-2 Infection and COVID-19 Disease Severity During Pregnancy and Postpartum

Lead Sponsor:

Barcelona Institute for Global Health

Collaborating Sponsors:

Hospital Clinic of Barcelona

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Conditions:

Pregnancy Related

COVID

Eligibility:

FEMALE

Phase:

PHASE3

Brief Summary

It still unclear how SARS-CoV-2 affects pregnant women and their offspring, as well as which factors may influence obstetrical disease and outcomes, including the timing of maternal viral exposure by ...

Detailed Description

This is a randomized, double blinded, placebo-controlled multicenter clinical trial including 714 pregnant women (200 SARS-CoV-2 infected -100 symptomatic with mild disease and 100 asymptomatic- pregn...

Eligibility Criteria

Inclusion

  • Presenting with fever (≥37.5ºC) and/or one mild symptom suggestive of COVID-19 disease (cough, dyspnoea, chills, odynophagia, diarrhoea, muscle pain, anosmia, taste disorder, headache) OR contact of a SARS-CoV-2 confirmed or suspected case in the past 14 days
  • More than 12 weeks of gestation (dated by ultrasonography)
  • Agreement to deliver in the study hospitals

Exclusion

  • Known hypersensitivity to HCQ or other 4-aminoquinoline compounds
  • History of retinopathy of any aetiology
  • Concomitant use of digoxin, cyclosporine, cimetidine
  • Known liver disease
  • Clinical history of cardiac pathology including known long QT syndrome
  • Unable to cooperate with the requirements of the study
  • Participating in other intervention studies
  • Delivery onset (characterized by painful uterine contractions and variable changes of the cervix, including some degree of effacement and slower progression of dilatation up to 5 cm for first and subsequent labours)

Key Trial Info

Start Date :

May 13 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 31 2021

Estimated Enrollment :

129 Patients enrolled

Trial Details

Trial ID

NCT04410562

Start Date

May 13 2020

End Date

October 31 2021

Last Update

January 12 2022

Active Locations (9)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (9 locations)

1

Hospital General de Segovia

Segovia, Cartilla Y León, Spain, 40002

2

Hospital del Mar

Barcelona, Catalonia, Spain, 08003

3

Hospital Clínic de Barcelona

Barcelona, Catalonia, Spain, 08036

4

Hospital de la Sant Creu i Sant Pau

Barcelona, Catalonia, Spain, 08041